Regulus Therapeutics Inc.
USD8.16
+0.00 (+0.00%)
CEO
Joseph P. Hagan
IPO Date
2012-10-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.16
Prev. Close
$8.16
Day Low
$8.16
Day High
$8.16
52W Low
$0.83
52W High
$8.35
Market Cap
$0.56B
Volume
8.76M
| -0.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -85.1% | -60.6% | 0.19 | 3.78 | -0.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -50.6% | -40.6% | 0.13 | 12.48 | -1.0 |
| 31 Dec 2020 | FY | 99.8% | -157.2% | -60.4% | -41.8% | 0.18 | 3.17 | -3.0 |
| 31 Dec 2019 | FY | 99.8% | -272.1% | -92.9% | -44.2% | 0.73 | 1.87 | -0.8 |
| 31 Dec 2018 | FY | -47087.5% | -67651.4% | 832.1% | -174.4% | -2.83 | 0.72 | -0.2 |
| 31 Dec 2017 | FY | -75720.8% | -99868.1% | -204.2% | -92.4% | 0.56 | 2.05 | -1.5 |
| 31 Dec 2016 | FY | -5285.7% | -6853.9% | -145.9% | -81.3% | 0.35 | 6.37 | -1.5 |
| 31 Dec 2015 | FY | -171.6% | -268.5% | -44.9% | -39.5% | 0.00 | 11.74 | -8.0 |
| -2.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -16.2% | -15.0% | 0.01 | 14.14 | -1.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -11.2% | -10.6% | 0.01 | 19.06 | -2.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -7.9% | -7.4% | 0.02 | 17.32 | -2.4 |
| 31 Dec 2023 | Q4 | -25.2% | -2669.2% | -38.0% | -26.2% | 0.11 | 3.31 | -0.8 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -27.7% | -20.7% | 0.12 | 4.25 | -0.9 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -20.6% | -16.1% | 0.13 | 5.03 | -1.0 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -26.7% | -19.2% | 0.20 | 3.92 | -0.5 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -20.4% | -14.5% | 0.19 | 3.78 | -0.8 |